Trial Profile
A Tolerance and Efficacy Trial of Preoperative Thalidomide Treatment Followed by Radical Retropubic Prostatectomy (RRP) in Select Patients With Locally Advanced Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 22 Aug 2009 New trial record
- 22 Aug 2009 New trial record